IP Library Granted Patent US 7,371,772
Granted Patent B2
US 7,371,772 · App. 10/484,762 · Granted May 13, 2008

Bicyclic compound, production and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,371,772
App. No.
10/484,762
Granted
May 13, 2008
Kind
B2
Abstract

The present invention provides a new cyclic compound having a CCR antagonist activity, especially a CCR5 antagonist activity, and the use thereof. The compound of the present invention is represented by the formula: wherein, R 1 is a 5- to 6-membered ring group which may be substituted; X 1 is a bond or the like; ring A is a 5- to 6-membered ring group which may be substituted; ring B is a 8- to 10-membered ring group which may be substituted; X 2 is a bivalent group of 1 to 4 atoms; Z 1 is a bivalent cyclic ring group or the like; Z 2 is a bond or the like; and R 2 is an amino group, a nitrogen-containing heterocyclic group which may be substituted or the like, or a salt thereof.

Claims (1)

1. (S)-8-[4-(2-Butoxyethoxy)phenyl]-1-isobutyl-N-(4-{[(1-propyl-1H-imidaxol-5-yl)methyl]sulfinyl}phenyl)-1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide, (S)-8-[4-(2-butoxyothoxy) or a salt thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2008
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: TOBIRA THERAPEUTICS, INC.
Reel/Frame 021489/0085 →
CHANGE OF NAME Recorded May 16, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016891/0046 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2004
From: SHIRAISHI, MITSURU; BABA, MASANORI; AIKAWA, KATSUJI; KANAZAKI, NAOYUKI; SETO, MASAKI; IIZAWA, YUJI
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 015601/0107 →